| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Bladder cancer survival: Women better off in the long run
|
Andreassen, Bettina Kulle
|
|
2018
|
95 |
C |
p. 52-58
|
artikel
|
| 2 |
Concurrent radiotherapy and nivolumab in metachronous metastatic primary adenosquamous-cell carcinoma of the prostate
|
Eze, Chukwuka
|
|
2018
|
95 |
C |
p. 109-111
|
artikel
|
| 3 |
Distinguishing between immune-related pneumonitis and disease progression in advanced Non Small Cell Lung Cancer treated with PD-1 inhibitors: Can serum tumour markers have a role?
|
Dall'Olio, Filippo Gustavo
|
|
2018
|
95 |
C |
p. 127-129
|
artikel
|
| 4 |
Dose-dependent toxicity of ipilimumab in metastatic melanoma
|
Olischewsky, Alexandra
|
|
2018
|
95 |
C |
p. 104-108
|
artikel
|
| 5 |
Elevated cancer risk in Holocaust survivors residing in Israel: A retrospective cohort study
|
Ben David, Ran
|
|
2018
|
95 |
C |
p. 85-92
|
artikel
|
| 6 |
Endocrine therapy or chemotherapy as first-line therapy in hormone receptor–positive HER2-negative metastatic breast cancer patients
|
Jacquet, E.
|
|
2018
|
95 |
C |
p. 93-101
|
artikel
|
| 7 |
Focal immune-related pancreatitis occurring after treatment with programmed cell death 1 inhibitors: a distinct form of autoimmune pancreatitis?
|
Capurso, Gabriele
|
|
2018
|
95 |
C |
p. 123-126
|
artikel
|
| 8 |
Heterogeneity of mismatch repair defect in colorectal cancer and its implications in clinical practice
|
Tachon, Gaelle
|
|
2018
|
95 |
C |
p. 112-116
|
artikel
|
| 9 |
Immune checkpoint therapy in proteinuric kidney disease
|
Takenaka, Tsuneo
|
|
2018
|
95 |
C |
p. 120-122
|
artikel
|
| 10 |
Immunotherapy phase I trials in patients Older than 70 years with advanced solid tumours
|
Herin, H.
|
|
2018
|
95 |
C |
p. 68-74
|
artikel
|
| 11 |
Is alpha-fetoprotein decline a prognostic factor of childhood non-seminomatous germ cell tumours? Results of the French TGM95 study
|
Fresneau, B.
|
|
2018
|
95 |
C |
p. 11-19
|
artikel
|
| 12 |
Late-occurring toxicity induced by an immune checkpoint blockade in adjuvant treatment of a stage III melanoma patient
|
Mandalà, Mario
|
|
2018
|
95 |
C |
p. 130-132
|
artikel
|
| 13 |
Letter to the Editor: Central nervous system relapse rate and dose intensification in poor risk metastatic germ cell tumours—A comment on: ‘Patterns of relapse in poor prognosis germ cell tumours in the GETUG-13 trial: Implications for the assessment of brain metastases.’ by Loriot and colleagues
|
Alifrangis, Constantine
|
|
2018
|
95 |
C |
p. 102-103
|
artikel
|
| 14 |
Most adolescents' melanomas are conventional malignant adult-type melanomas
|
Rose, Klaus
|
|
2018
|
95 |
C |
p. 117-119
|
artikel
|
| 15 |
Phase I feasibility study for intrathecal administration of trastuzumab in patients with HER2 positive breast carcinomatous meningitis
|
Bonneau, Claire
|
|
2018
|
95 |
C |
p. 75-84
|
artikel
|
| 16 |
Rational design and identification of immuno-oncology drug combinations
|
Iafolla, Marco A.J.
|
|
2018
|
95 |
C |
p. 38-51
|
artikel
|
| 17 |
Surgical resection versus systemic therapy for breast cancer liver metastases: Results of a European case matched comparison
|
Ruiz, A.
|
|
2018
|
95 |
C |
p. 1-10
|
artikel
|
| 18 |
The role of genomic profiling in adolescents and young adults (AYAs) with advanced cancer participating in phase I clinical trials
|
McVeigh, Terri Patricia
|
|
2018
|
95 |
C |
p. 20-29
|
artikel
|
| 19 |
Treatment decisions and the impact of adverse events before and during extended endocrine therapy in postmenopausal early breast cancer
|
Blok, Erik J.
|
|
2018
|
95 |
C |
p. 59-67
|
artikel
|
| 20 |
5-year overall survival after early breast cancer diagnosed during pregnancy: A retrospective case-control multicentre French study
|
Ploquin, A.
|
|
2018
|
95 |
C |
p. 30-37
|
artikel
|
Tijdschrift beschrijving